Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice

Journal of the American Society of Nephrology

Volumn 16, Issue 2, 2005, Pages 363-373

  Lassila, Markus ^a   Jandeleit Dahm, Karin ^a   Seah, Kwee K ^a   Smith, Craig M ^a   Calkin, Anna C ^a,b   Allen, Terri J ^a   Cooper, Mark E ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; APOLIPOPROTEIN E; COLLAGEN TYPE 1; GROWTH FACTOR; IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR; STREPTOZOCIN; PIPERAZINE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PYRIMIDINE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; GENE EXPRESSION; GLOMERULUS; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY TUBULE; KNOCKOUT MOUSE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; UPREGULATION; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; KIDNEY FUNCTION TEST; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; NEEDLE BIOPSY; NUCLEOTIDE SEQUENCE; PATHOLOGY; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ANIMALS; APOLIPOPROTEINS E; BASE SEQUENCE; BIOPSY, NEEDLE; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION TESTS; MALE; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PIPERAZINES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA;

EID: 20544477176     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004050392     Document Type: Article

References (36)

1. Cooper ME: Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 44: 1957-1972, 2001
2. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996
3. Heldin CH, Westermark B: Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316, 1999
4. Bonner JC: Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 15: 255-273, 2004
5. Nakagawa T, Sasahara M, Haneda M, Kataoka H, Nakagawa H, Yagi M, Kikkawa R, Hazama F: Role of PDGF B-chain and PDGF receptors in rat tubular regeneration after acute injury. Am J Pathol 155: 1689-1699, 1999
6. Tang WW, Ulich TR, Lacey DL, Hill DC, Qi M, Kaufman SA, Van GY, Tarpley JE, Yee JS: Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 148: 1169-1180, 1996
7. Abboud HE: Role of platelet-derived growth factor in renal injury. Annu Rev Physiol 57: 297-309, 1995
8. Savikko J, Taskinen E, Von Willebrand E: Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: Tyrosine kinase inhibitors as a potential therapy. Transplantation 75: 1147-1153, 2003
9. Gilbert RE, Kelly DJ, McKay T, Chadban S, Hill PA, Cooper ME, Atkins RC, Nikolic-Paterson DJ: PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int 59: 1324-1332, 2001
10. Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, Koide H: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42: 450-456, 1993
11. Nakagawa H, Sasahara M, Haneda M, Koya D, Hazama F, Kikkawa R: Immunohistochemical characterization of glomerular PDGF B-chain and PDGF beta-receptor expression in diabetic rats. Diabetes Res Clin Pract 48: 87-98, 2000
12. Kelly DJ, Gilbert RE, Cox AJ, Soulis T, Jerums G, Cooper ME: Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy. J Am Soc Nephrol 12: 2098-2107, 2001
13. Langham RG, Kelly DJ, Maguire J, Dowling JP, Gilbert RE, Thomson NM: Over-expression of platelet-derived growth factor in human diabetic nephropathy. Nephrol Dial Transplant 18: 1392-1396, 2003
14. Lassila M, Allen TJ, Cao Z, Thallas V, Jandeleit-Dahm KA, Candido R, Cooper ME: Imatinib attenuates diabetes-associated atherosclerosis. Arterioscler Thromb Vasc Biol 24: 935-942, 2004
15. Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA: Accelerated nephropathy in diabetic apolipoprotein E-knockout mouse- role of advanced glycation end products. J Am Soc Nephrol 15: 2125-2138, 2004
16. Candido R, Jandeleit-Dahm KA, Cao Z, Nesteroff SP, Burns WC, Twigg SM, Dilley RJ, Cooper ME, Allen TJ: Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation 106: 246-253, 2002
17. Krege JH, Hodgin JB, Hagaman JR, Smithies O: A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 25: 1111-1115, 1995
18. Allen TJ, Cooper ME, O'Brien RC, Bach LA, Jackson B, Jerums G: Glomerular filtration rate in streptozocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy. Diabetes 39: 1182-1190, 1990
19. Kelly DJ, Wilkinsonberka JL, Allen TJ, Cooper ME, Skinner SL: A new model of diabetic nephropathy with progressive renal impairment in the transgenic (Mren-2)27 rat (Tgr). Kidney Int 54: 343-352, 1998
20. Hewitson TD, Darby IA, Bisucci T, Jones CL, Becker GJ: Evolution of tubulointerstitial fibrosis in experimental renal infection and scarring. J Am Soc Nephrol 9: 632-642, 1998
21. Cohen MP, Lautenslager GT, Shearman CW: Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice. Metabolism 50: 1435-1440, 2001
22. Hume DA, Gordon S: Mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Identification of resident macrophages in renal medullary and cortical interstitium and the juxtaglomerular complex. J Exp Med 157: 1704-1709, 1983
23. Bonnet F, Cooper ME, Carey RM, Casley D, Cao Z: Vascular expression of angiotensin type 2 receptor in the adult rat: Influence of angiotensin II infusion. J Hypertens 19: 1075-1081, 2001
24. Cooper ME, Thomas MC: Interactions between growth factors in the kidney: Implications for progressive renal injury. Kidney Int 63: 1584-1585, 2003
25. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG, Seidel K: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47: 935-944, 1995
26. Nabokov A, Waldherr R, Ritz E: Demonstration of the proliferation marker Ki-67 in renal biopsies: Correlation to clinical findings. Am J Kidney Dis 30: 87-97, 1997
27. Blom IE, van Dijk AJ, Wieten L, Duran K, Ito Y, Kleij L, deNichilo M, Rabelink TJ, Weening JJ, Aten J, Goldschmeding R: In vitro evidence for differential involvement of CTGF, TGFβ, and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant 16: 1139-1148, 2001
28. Pedagogos E, Hewitson T, Fraser I, Nicholls K, Becker G: Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy. Am J Kidney Dis 29: 912-918, 1997
29. Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME: Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108: 1853-1863, 2001
30. Hudkins KL, Gilbertson DG, Carling M, Taneda S, Hughes SD, Holdren MS, Palmer TE, Topouzis S, Haran AC, Feldhaus AL, Alpers CE: Exogenous PDGF-D is a potent mesangial cell mitogen and causes a severe mesangial proliferative glomerulopathy. J Am Soc Nephrol 15: 286-298, 2004
31. Ostendorf T, Kunter U, Grone HJ, Bahlmann F, Kawachi H, Shimizu F, Koch KM, Janjic N, Floege J: Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 12: 909-918, 2001
32. Fraser D, Brunskill N, Ito T, Phillips A: Long-term exposure of proximal tubular epithelial cells to glucose induces transforming growth factor-beta 1 synthesis via an autocrine PDGF loop. Am J Pathol 163: 2565-2574, 2003
33. Fraser D, Wakefield L, Phillips A: Independent regulation of transforming growth factor-β1 transcription and translation by glucose and platelet-derived growth factor. Am J Pathol 161: 1039-1049, 2002
34. Ostendorf T, Kunter U, van Roeyen C, Dooley S, Janjic N, Ruckman J, Eitner F, Floege J: The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system. J Am Soc Nephrol 13: 658-667, 2002
35. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB: Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2: 561-566, 1996
36. Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Druker BJ, Lydon NB: Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 56: 100-104, 1996